Charles Schwab Investment Management Inc Bioventus Inc. Transaction History
Charles Schwab Investment Management Inc
- $429 Billion
- Q1 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Bioventus Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 185,651 shares of BVS stock, worth $1.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
185,651
Previous 180,546
2.83%
Holding current value
$1.07 Million
Previous $951,000
1.47%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding BVS
# of Institutions
89Shares Held
35.7MCall Options Held
167KPut Options Held
126K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$74.9 Million19.68% of portfolio
-
Juniper Investment Company, LLC New York, NY6.83MShares$39.3 Million18.22% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT5.81MShares$33.4 Million1.94% of portfolio
-
Sv Health Investors, LLC Boston, MA1.49MShares$8.56 Million32.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.22MShares$7.01 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $355M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...